Rowan Radford

Rowan Radford is a Researcher at the Macquarie Medical School, affiliated with the Motor Neuron Disease Research Centre at Macquarie University. His work focuses on neurodegenerative diseases, particularlyMultiple System Atrophy (MSA), Amyotrophic Lateral Sclerosis (ALS), and Progressive Supranuclear Palsy (PSP). He employs molecular biology, proteomics, and zebrafish models to study proteinopathies like TDP-43 and Tau aggregation.

• Current Roles: Research Assistant, Macquarie Medical School; Professional Casual in Deputy Vice-Chancellor (Research) - Office
• Key Research Outputs: 24 total publications (2014–2025), including high-impact work on TDP-43 phase separation and microglia diversity
• Metrics: h-index 12, 787 citations (Scopus), 163 citations for 2022 review on microglia

His research explores:

• Protein Aggregation Dynamics: Role of lysine residues in TDP-43 pathology, RNA-binding regulation of protein homeostasis
• Neuroimmune Mechanisms: Microglia morphophysiological diversity in CNS
• Tau Protein Networks: Interactors in PSP related to protein degradation and neurotransmission
• Synucleinopathies: Alpha-synuclein aggregation in MSA

Recent publications (2022–2025) analyze:

• TDP-43 condensate formation
• Tau-phosphorylation interactions
• Microglia functional heterogeneity
• Alpha-synuclein inclusion bodies
• Protein degradation pathways in neurodegeneration
• CNS metabolic dysregulation

Key collaborations with researchers like Lee, Chung, and Morsch across neuroscience and molecular biology disciplines. His work has been referenced inWikipedia and picked up by multiple news outlets.